Skip to main content
. Author manuscript; available in PMC: 2024 Jan 17.
Published in final edited form as: Acc Chem Res. 2022 Dec 29;56(2):157–168. doi: 10.1021/acs.accounts.2c00735

Figure 3.

Figure 3.

SARS-CoV-2 Mpro inhibitors identified from screening a protease inhibitor library. X-ray crystal structures of SARS-CoV-2 Mpro with GC376 (PDB: 6WTT) (A), calpain inhibitor II (PDB: 6XA4) (B), calpain inhibitor XII (PDB: 6XFN) (C), and boceprevir (PDB: 6XQU) (D). (E) Chemical structures of GC376, calpain inhibitors II and XII, and boceprevir and their enzymatic inhibitory activity against SARS-CoV-2 Mpro and host cathepsin L. N.T. = not tested.